Bioequivalence of HTX-019 (aprepitant IV) and fosaprepitant in healthy subjects: a Phase I, open-label, randomized, two-way crossover evaluation
Ottoboni, Tom, Keller, Mary Rose, Cravets, Matt, Clendeninn, Neil, Quart, Barry
Published in Drug design, development and therapy (01.03.2018)
Published in Drug design, development and therapy (01.03.2018)
Get full text
Journal Article
Multicenter Phase I Trial of the Mitogen-Activated Protein Kinase 1/2 Inhibitor BAY 86-9766 in Patients with Advanced Cancer
WEEKES, Colin D, VON HOFF, Daniel D, MA, Wen W, SHEEDY, Beth, IVERSON, Cory, MINER, Jeffrey N, ZANCONG SHEN, YEH, Li-Tain, DUBOWY, Ronald L, JEFFERS, Michael, RAJAGOPALAN, Prabhu, CLENDENINN, Neil J, ADJEI, Alex A, LEFFINGWELL, Diane P, ECKHARDT, S. Gail, GORE, Lia, LEWIS, Karl D, WEISS, Glen J, RAMANATHAN, Ramesh K, DY, Grace K
Published in Clinical cancer research (01.03.2013)
Published in Clinical cancer research (01.03.2013)
Get full text
Journal Article
A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer
Adjei, Alex A, Richards, Donald A, El-Khoueiry, Anthony, Braiteh, Fadi, Becerra, Carlos H R, Stephenson, Jr, Joe J, Hezel, Aram F, Sherman, Morris, Garbo, Lawrence, Leffingwell, Diane P, Iverson, Cory, Miner, Jeffrey N, Shen, Zancong, Yeh, Li-Tain, Gunawan, Sonny, Wilson, David M, Manhard, Kimberly J, Rajagopalan, Prabhu, Krissel, Heiko, Clendeninn, Neil J
Published in Clinical cancer research (15.05.2016)
Published in Clinical cancer research (15.05.2016)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of Prinomastat, a Matrix Metalloprotease Inhibitor
HANDE, Kenneth R, COLLIER, Mary, PARADISO, Linda, STUART-SMITH, Jill, DIXON, Mary, CLENDENINN, Neil, YEUN, Geoff, ALBERTI, Donna, BINGER, Kim, WILDING, George
Published in Clinical cancer research (01.02.2004)
Published in Clinical cancer research (01.02.2004)
Get full text
Journal Article
A Preliminary Evaluation of Nelfinavir Mesylate, an Inhibitor of Human Immunodeficiency Virus (HIV)-1 Protease, to Treat HIV Infection
Markowitz, Martin, Conant, Marcus, Hurley, Arlene, Schluger, Rosemary, Duran, Margarita, Peterkin, Joanna, Chapman, Sharon, Patick, Amy, Hendricks, Amy, Yuen, Geoffrey J., Hoskins, William, Clendeninn, Neil, Ho, David D.
Published in The Journal of infectious diseases (01.06.1998)
Published in The Journal of infectious diseases (01.06.1998)
Get full text
Journal Article
Short-Term Measures of Relative Efficacy Predict Longer-Term Reductions in Human Immunodeficiency Virus Type 1 RNA Levels following Nelfinavir Monotherapy
MITTLER, John, ESSUNGER, Paulina, YUEN, Geoffrey J, CLENDENINN, Neil, MARKOWITZ, Martin, PERELSON, Alan S
Published in Antimicrobial Agents and Chemotherapy (01.05.2001)
Published in Antimicrobial Agents and Chemotherapy (01.05.2001)
Get full text
Journal Article
The Pharmacology and Clinical Use of Methotrexate
Jolivet, Jacques, Cowan, Kenneth H, Curt, Gregory A, Clendeninn, Neil J, Chabner, Bruce A
Published in The New England journal of medicine (03.11.1983)
Published in The New England journal of medicine (03.11.1983)
Get full text
Journal Article
Hypersensitivity and infusion-site adverse events with intravenous fosaprepitant after anthracycline-containing chemotherapy: a retrospective study
Boccia, Ralph, Geller, Robert B, Clendeninn, Neil, Ottoboni, Thomas
Published in Future oncology (London, England) (01.01.2019)
Published in Future oncology (London, England) (01.01.2019)
Get full text
Journal Article
Phase I Studies with the Nonclassical Antifolate Nolatrexed Dihydrochloride (AG337, THYMITAQ) Administered Orally for 5 Days
HUGHES, A. N, RAFI, I, GRIFFIN, M. J, CALVERT, A. H, NEWELL, D. R, CALVETE, J. A, JOHNSTON, A, CLENDENINN, N, BODDY, A. V
Published in Clinical cancer research (01.01.1999)
Get full text
Published in Clinical cancer research (01.01.1999)
Journal Article
Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder
KHORSAND, M, LANGE, J, FEUN, L, CLENDENINN, N. J, COLLIER, M, WILDING, G
Published in Investigational new drugs (01.01.1997)
Published in Investigational new drugs (01.01.1997)
Get full text
Journal Article
HTX-019 via 2-min injection or 30-min infusion in healthy subjects
Ottoboni, Thomas, Lauw, Michael, Keller, Mary Rose, Cravets, Matt, Manhard, Kimberly, Clendeninn, Neil, Quart, Barry
Published in Future oncology (London, England) (01.03.2019)
Published in Future oncology (London, England) (01.03.2019)
Get full text
Journal Article
Bioequivalence of HTX-019
Keller, Mary Rose, Quart, Barry, Ottoboni, Tom, Clendeninn, Neil, Cravets, Matt
Published in Drug design, development and therapy (01.01.2018)
Get full text
Published in Drug design, development and therapy (01.01.2018)
Journal Article
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule
ADAMSON, P. C, BALIS, F. M, MISER, J, ARNDT, C, WELLS, R. J, GILLESPIE, A, ARONSON, L, PENTA, J. S, CLENDENINN, N. J, POPLACK, D. G
Published in Cancer research (Chicago, Ill.) (01.02.1992)
Get full text
Published in Cancer research (Chicago, Ill.) (01.02.1992)
Journal Article
Predictors of optimal virological response to potent antiretroviral therapy
POWDERLY, W. G, SAAG, M. S, CHAPMAN, S, YU, G, QUART, B, CLENDENINN, N. J
Published in AIDS (London) (01.10.1999)
Published in AIDS (London) (01.10.1999)
Get full text
Journal Article
Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule
Adamson, P C, Balis, F M, Miser, J, Wells, R J, Bleyer, W A, Williams, T E, Gillespie, A, Penta, J S, Clendeninn, N J, Poplack, D G
Published in Cancer research (Chicago, Ill.) (01.08.1990)
Get full text
Published in Cancer research (Chicago, Ill.) (01.08.1990)
Journal Article
Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma
Jhawer, Minaxi, Rosen, Lee, Dancey, Janet, Hochster, Howard, Hamburg, Solomon, Tempero, Margaret, Clendeninn, Neil, Mani, Sridhar
Published in Investigational new drugs (01.02.2007)
Published in Investigational new drugs (01.02.2007)
Get full text
Journal Article
Abstract A88: Safety, pharmacokinetic, and pharmacodynamic results of BAY 86–9766, an oral MEK inhibitor, in combination with sorafenib, an oral multikinase inhibitor, in advanced cancer patients
Adjei, Alex A., Richards, Donald A., El-Khoueiry, Anthony, Becerra, Carlos H.R., Stephenson, Joe J., Leffingwell, Diane P., Iverson, Cory, Miner, Jeffrey N., Shen, Zancong, Gunawan, Sonny, Wilson, David, Manhard, Kimberly J., Dubowy, Ron L., Jeffers, Michael, Rajagopalan, Prabhu, Franklin, Wilbur A., Haney, Jerry, Lenhart, Patricia, Clendeninn, Neil J.
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article
Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511)
SAAG, Michael S, TEBAS, Pablo, SENSION, Michael, CONANT, Marcus, MYERS, Robert, CHAPMAN, Sharon K, ANDERSON, Robert, CLENDENINN, Neil
Published in AIDS (London) (19.10.2001)
Published in AIDS (London) (19.10.2001)
Get full text
Journal Article